Global Next Generation Sequencing Market Growth: Industry Size, Analysis and Forecast

Report ID : 1344167 | Published : March 2025 | Study Period : 2023-2033 | Format : PDF + Excel

The market size of the Next Generation Sequencing Market is categorized based on Technology (Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing (SMRT), Other Technologies) and Application (Clinical Diagnostics, Drug Discovery, Agricultural Biotechnology, Genomic Research, Other Applications) and Product (Instruments, Reagents, Software, Services, Consumables) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The market size of Next Generation Sequencing Market, valued at $10.5 billion in 2023, is projected to reach $22.5 billion by 2033, expanding at a CAGR of 7.8% between 2024 and 2033. The report comprises various segments and analyzes significant trends and factors influencing market growth.

The market for Next Generation Sequencing (NGS) is leading the global change in the analysis of genomes, dramatically impacting biotechnology and healthcare fields. With the increase in demand for fast and accurate methods of sequencing, NGS is able to provide full genetic profiling which allows researchers and clinicians to comprehend the human genome’s intricacies. This powerful technology improves the understanding of genetic diseases and provides the foundation for precision medicine – a key priority for developing modern healthcare systems.  

Technological development and lower prices have fueled growth in the NGS market. Industry leaders are constantly innovating, and as a result newer sequencing platforms, bioinformatics tools, and applications in oncology, reproductive health, and infectious disease are being developed. Organizations are looking to genomic data for better decisions, and the use of NGS in routine clinical practice is on the rise, marking a fundamental change in the development of diagnostic and therapeutic procedures.

While we analyze the Next Generation Sequencing market, understanding its intricacies across different segments, trends, and possibilities of growth is critical. Market research reports are a tremendous asset to businesses and stakeholders, helping them to navigate a rapidly changing environment. Organizations can position themselves to take advantage of the developments and innovations that will reshape the future of genomic science by comprehending the current environment and predicting what lies ahead.

 

ATTRIBUTES	DETAILS
STUDY PERIOD	2023-2033
BASE YEAR	2023
FORECAST PERIOD	2024-2033
HISTORICAL PERIOD	2023-2024
UNIT	VALUE (USD BILLION)
KEY COMPANIES PROFILED	Illumina Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., Oxford Nanopore Technologies Ltd., BGI Group, Roche Diagnostics, Qiagen N.V., Agilent Technologies Inc., Genomatix Software GmbH, PerkinElmer Inc., 10X Genomics Inc.
SEGMENTS COVERED	By Technology - Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing (SMRT), Other Technologies By Application - Clinical Diagnostics, Drug Discovery, Agricultural Biotechnology, Genomic Research, Other Applications By Product - Instruments, Reagents, Software, Services, Consumables By Geography - North America, Europe, APAC, Middle East Asia & Rest of World.

---

Next Generation Sequencing Market Dynamics

The Next Generation Sequencing Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.

Market Drivers

1. Technological Advancements
2. Increasing Consumer Demand
3. Regulatory Support
4. Globalization

Market Restraints

1. High Operational Costs
2. Regulatory Challenges
3. Market Saturation

Market Opportunities

1. Emerging Markets
2. Product Innovation
3. Strategic Partnerships

Market Challenges

1. Technological Disruptions
2. Supply Chain Issues
3. Changing Consumer Preferences

---

Key Players in the Next Generation Sequencing Market

This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.

• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Pacific Biosciences of California Inc.
• Oxford Nanopore Technologies Ltd.
• BGI Group
• Roche Diagnostics
• Qiagen N.V.
• Agilent Technologies Inc.
• Genomatix Software GmbH
• PerkinElmer Inc.
• 10X Genomics Inc.

---

Customization Options

Verified Industry Insights offers one of the following report customization options to our respectable clients :

Company Profiling

● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)

Competitive Benchmarking

● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research

Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439

© 2024 Verified Industry Insights. All Rights Reserved